# Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea

> **NCT00864812** · PHASE4 · COMPLETED · sponsor: **The Korean Academy of Tuberculosis and Respiratory Diseases** · enrollment: 509 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** tiotropium with fluticasone propionate/salmeterol (FSC)
- **DRUG:** tiotropium

## Key facts

- **NCT ID:** NCT00864812
- **Lead sponsor:** The Korean Academy of Tuberculosis and Respiratory Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2010-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864812, "Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00864812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*